Nuvectis Pharma NVCT
NASDAQ NVCT
$20.72 -0.40 (-1.89%)
At close: Oct 1, 2026 · 4:00 PM EDT

Nuvectis Pharma (NVCT) Cash from Financing Activities (2021 - 2026)

Updated

Nuvectis Pharma (NVCT) reported Cash from Financing Activities of $1.56 million for Q2 2026, up 427.4% from $296,000 a year earlier.

Analysis

Nuvectis Pharma (NVCT) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Nuvectis Pharma's Cash from Financing Activities came in at $14.88 million, down 29.4% year-over-year; for FY2025, it came in at $29.11 million, up 149.8% from FY2024.

  • Cash from Financing Activities has a four-year compound annual growth rate of 17.5% (FY2021 to FY2025).
  • By year, Cash from Financing Activities came in at $11.65 million in FY2024 (-22.8%), $15.09 million in FY2023 (-45.7%), $27.81 million in FY2022 (+82.4%) and $15.25 million in FY2021.
  • Five-year quarterly Cash from Financing Activities spans a low of -$578,000 in Q2 2022 and a high of $15.51 million in Q1 2025.
  • Year over year, Cash from Financing Activities gained in five of the last eight quarters, with growth averaging 200.8%.
  • The high point for year-over-year Cash from Financing Activities in five years was Q3 2025 (growth of 802.1%); the low point was Q1 2026 (a decline of 100.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $7,000 (Q1 2026), $166,000 (Q4 2025) and $13.14 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Nuvectis Pharma 563.79 Mn 563.79 Mn - 1.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.56 Mn
Mar 31, 2026 7,000.00
Dec 31, 2025 166,000.00
Sep 30, 2025 13.14 Mn
Jun 30, 2025 296,000.00
Mar 31, 2025 15.51 Mn
Dec 31, 2024 3.83 Mn
Sep 30, 2024 1.46 Mn
Jun 30, 2024 1.67 Mn
Mar 31, 2024 4.70 Mn
Dec 31, 2023 917,000.00
Sep 30, 2023 703,000.00
Jun 30, 2023 13.22 Mn
Mar 31, 2023 252,000.00
Dec 31, 2022 -131,000.00
Sep 30, 2022 14.49 Mn
Jun 30, 2022 -578,000.00
Mar 31, 2022 14.03 Mn
Sep 30, 2021 4.02 Mn
API Access

Nuvectis Pharma Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NVCT&period=max&api_key=YOUR_API_KEY